5nhy
From Proteopedia
(Difference between revisions)
m (Protected "5nhy" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==BAY-707 in complex with MTH1== | |
| + | <StructureSection load='5nhy' size='340' side='right' caption='[[5nhy]], [[Resolution|resolution]] 1.72Å' scene=''> | ||
| + | == Structural highlights == | ||
| + | <table><tr><td colspan='2'>[[5nhy]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5NHY OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5NHY FirstGlance]. <br> | ||
| + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=8XT:~{N}-ethyl-4-[(3~{S})-3-methylmorpholin-4-yl]-1~{H}-pyrrolo[2,3-b]pyridine-2-carboxamide'>8XT</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5nhy FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5nhy OCA], [http://pdbe.org/5nhy PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5nhy RCSB], [http://www.ebi.ac.uk/pdbsum/5nhy PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5nhy ProSAT]</span></td></tr> | ||
| + | </table> | ||
| + | == Function == | ||
| + | [[http://www.uniprot.org/uniprot/8ODP_HUMAN 8ODP_HUMAN]] Antimutagenic. Acts as a sanitizing enzyme for oxidized nucleotide pools, thus suppressing cell dysfunction and death induced by oxidative stress. Hydrolyzes 8-oxo-dGTP, 8-oxo-dATP and 2-OH-dATP, thus preventing misincorporation of oxidized purine nucleoside triphosphates into DNA and subsequently preventing A:T to C:G and G:C to T:A transversions. Able to hydrolyze also the corresponding ribonucleotides, 2-OH-ATP, 8-oxo-GTP and 8-oxo-ATP.<ref>PMID:10373420</ref> <ref>PMID:10608900</ref> <ref>PMID:11139615</ref> <ref>PMID:12857738</ref> <ref>PMID:22556419</ref> | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | MTH1 is a hydrolase responsible for sanitization of oxidized purine nucleoside triphosphates to prevent their incorporation into replicating DNA. Early tool compounds published in the literature inhibited the enzymatic activity of MTH1 and subsequently induced cancer cell death; however recent studies have questioned the reported link between these two events. Therefore, it is important to validate MTH1 as a cancer dependency with high quality chemical probes. Here, we present BAY-707, a substrate-competitive, highly potent and selective inhibitor of MTH1, chemically distinct compared to those previously published. Despite superior cellular target engagement and pharmacokinetic properties, inhibition of MTH1 with BAY-707 resulted in a clear lack of in vitro or in vivo anticancer efficacy either in mono- or in combination therapies. Therefore, we conclude that MTH1 is dispensable for cancer cell survival. | ||
| - | + | Novel Class of Potent and Cellularly Active Inhibitors Devalidates MTH1 as Broad-Spectrum Cancer Target.,Ellermann M, Eheim A, Rahm F, Viklund J, Guenther J, Andersson M, Ericsson U, Forsblom R, Ginman T, Lindstrom J, Silvander C, Tresaugues L, Giese A, Bunse S, Neuhaus R, Weiske J, Quanz M, Glasauer A, Nowak-Reppel K, Bader B, Irlbacher H, Meyer H, Queisser N, Bauser M, Haegebarth A, Gorjanacz M ACS Chem Biol. 2017 Aug 18;12(8):1986-1992. doi: 10.1021/acschembio.7b00370. Epub, 2017 Jul 12. PMID:28679043<ref>PMID:28679043</ref> | |
| - | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
| - | [[Category: | + | </div> |
| + | <div class="pdbe-citations 5nhy" style="background-color:#fffaf0;"></div> | ||
| + | == References == | ||
| + | <references/> | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Andersson, M]] | ||
| + | [[Category: Bader, B]] | ||
| + | [[Category: Bunse, S]] | ||
| + | [[Category: Eheim, A]] | ||
| + | [[Category: Ellermann, M]] | ||
| + | [[Category: Ericsson, U]] | ||
| + | [[Category: Forsblom, R]] | ||
| + | [[Category: Giese, A]] | ||
| + | [[Category: Ginman, T]] | ||
| + | [[Category: Glasauer, A]] | ||
| + | [[Category: Gorjanacz, M]] | ||
| + | [[Category: Irlbacher, H]] | ||
| + | [[Category: Lindstrom, J]] | ||
| + | [[Category: Meyer, H]] | ||
| + | [[Category: Neuhaus, R]] | ||
| + | [[Category: Nowak-Reppel, K]] | ||
| + | [[Category: Quanz, M]] | ||
| + | [[Category: Queisser, N]] | ||
| + | [[Category: Rahm, F]] | ||
| + | [[Category: Silvander, C]] | ||
| + | [[Category: Tresaugues, L]] | ||
| + | [[Category: Viklund, J]] | ||
| + | [[Category: Weiske, J]] | ||
| + | [[Category: Hydrolase]] | ||
| + | [[Category: Inhibitor]] | ||
| + | [[Category: Nucleotide hydrolase]] | ||
| + | [[Category: Nudix]] | ||
| + | [[Category: Oncology]] | ||
Revision as of 04:04, 30 August 2017
BAY-707 in complex with MTH1
| |||||||||||
Categories: Andersson, M | Bader, B | Bunse, S | Eheim, A | Ellermann, M | Ericsson, U | Forsblom, R | Giese, A | Ginman, T | Glasauer, A | Gorjanacz, M | Irlbacher, H | Lindstrom, J | Meyer, H | Neuhaus, R | Nowak-Reppel, K | Quanz, M | Queisser, N | Rahm, F | Silvander, C | Tresaugues, L | Viklund, J | Weiske, J | Hydrolase | Inhibitor | Nucleotide hydrolase | Nudix | Oncology
